Disulfiram (DSF), traditionally used to treat alcohol dependence, has recently emerged as a potent inhibitor of the NLRP3 inflammasome, offering a novel immunomodulatory strategy in gout management [35,36,37]. This evidence concerns the gene NLRP3 and gout.